Profil
Dorothee Holm-von Laer is associated with ViraTherapeutics GmbH as the founder.
She held the position of Chief Executive & Scientific Officer from 2013 to 2017.
ViraTherapeutics GmbH was founded in 2013.
Anciens postes connus de Dorothee Holm-von Laer
| Sociétés | Poste | Fin |
|---|---|---|
ViraTherapeutics GmbH
 ViraTherapeutics GmbH BiotechnologyHealth Technology ViraTherapeutics GmbH is a biopharmaceutical company that develops virus-based immunotherapeutics for cancer treatment. It specializes in the development of oncolytic cancer vaccines based on Vesicular Stomatitis Virus Glycoprotein G (VSV-GP). The company was founded by Dorothee Holm-von Laer in 2013 and is headquartered in Innsbruck, Austria. | Directeur Général | 30/05/2017 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
ViraTherapeutics GmbH
ViraTherapeutics GmbH BiotechnologyHealth Technology ViraTherapeutics GmbH is a biopharmaceutical company that develops virus-based immunotherapeutics for cancer treatment. It specializes in the development of oncolytic cancer vaccines based on Vesicular Stomatitis Virus Glycoprotein G (VSV-GP). The company was founded by Dorothee Holm-von Laer in 2013 and is headquartered in Innsbruck, Austria. | Health Technology |
